| Protein group (n = 14) | Control group (n = 17) | p valueb | ||||
---|---|---|---|---|---|---|---|
Mean (25th–75th ) | Mean (25th–75th ) | p valuea | Mean (25th–75th ) | Mean (25th–75th) | p valuea | ||
Baseline | End of study | Baseline | end of Study | ||||
Serum IGF-1 (ng/ml)c | 70 (57–81) | 75 (62–91) | 0.08* | 74 (60–87) | 73 (64–85) | 0.68* | 0.07 |
Plasma GIP (pg/ml)d | 136 (79–178) | 119 (100–124) | 0.51# | 125 (94–155) | 171 (101–200) | 0.10# | 0.10 |
Plasma GLP-1 (pg/ml)d | 46 (19–51) | 42 (22–45) | 0.78# | 39 (29–47) | 43 (31–49) | 0.62# | 0.78 |
Plasma PP (pg/ml)d | 287 (150–463) | 287 (154–419) | 0.55# | 225 (153–318) | 230 (108–244) | 0.33# | 0.32 |
Plasma Amylin (pg/ml)d | 397 (313–461)* | 393 (213–509) | 0.86# | 372 (213–337) | 336 (216–351) | 0.92# | 0.82 |
Plasma PYY (pg/ml)d | 347 (297–400)* | 351 (285–440) | 0.86# | 340 (285–353) | 335 (290–376) | 0.94# | 0.63 |